Key result
Isoproterenol drives cardiac fibrosis and inflammation in mice via P2X7-NEK7-mediated NLRP3 inflammasome activation.
Why the study?
The mechanisms driving cardiac NLRP3 inflammasome assembly and activation during beta-adrenergic overactivation remained poorly understood.
Does the P2X7-NEK7-NLRP3 axis drive cardiac inflammation and fibrosis in isoproterenol-induced cardiac remodeling in mice?
Does the P2X7-NEK7-NLRP3 axis drive cardiac inflammation and fibrosis in isoproterenol-induced cardiac remodeling in mice?
The P2X7-NEK7 pathway activates the NLRP3 inflammasome early in beta-adrenergic insult, driving cardiac fibrosis and inflammation in a mouse model.
Answers are grounded in this paper and cite their sources.
NLRP3 axis in isoproterenol remodeling is hypothesis-generating in mice; human studies needed before any clinical inference.
AIM: Cardiac remodeling (CR) is a critical risk factor for the development and progression of cardiovascular diseases. CR is accompanied by activation of the innate immune response, with NLRP3 inflammasome emerging as a key player in morphological and functional changes. However, the mechanisms underlying NLRP3 inflammasome assembly and activation in the heart upon beta-adrenergic overactivation remain poorly understood. This study aims to investigate the temporal profile of NLRP3 inflammasome activation and its upstream signaling P2X7-NEK7 in isoproterenol (ISO)-induced CR. METHODS: Wild-type (WT), NLRP3 knockout (NLRP3-KO), and P2X7-KO male mice were treated with ISO (60 mg/kg) for 1 h, 12 h, 24 h, or 14 days. Cardiac function was assessed by echocardiography and plethysmography. Cardiac hypertrophy and fibrosis were evaluated by histology. Fibrosis markers and cytokines gene expression were analyzed by quantitative PCR. Protein expression was evaluated by Western Blotting. Inflammasome assembly was confirmed by ASC speck immunofluorescence. RESULTS: WT mice showed a rapid activation of NLRP3 inflammasome in the heart up to 12 h from ISO administration, evidenced by increased NLRP3, ASC speck, Caspase-1, and IL-1β. ISO treatment for 12 h also increased P2X7 and NEK7. NLRP3-KO mice were protected from ISO-induced fibrosis and impairment of LV relaxation as well as the Caspase-1 activation and cytokines production. NEK7, NLRP3 activation, and fibrosis were prevented in P2X7-KO. NLRP3 deletion did not affect ISO-induced cardiac hypertrophy. CONCLUSION: These findings suggest that the NLRP3 inflammasome is activated by the P2X7-NEK7 pathway in the early stage of beta-adrenergic insult, driving ISO-induced cardiac fibrosis and inflammation.
No takes yet. Share an insight, caveat, or question.
Parletta et al. (2026) studied Cardiac remodeling. Isoproterenol was evaluated on NLRP3 inflammasome activation, cardiac hypertrophy, and fibrosis. Isoproterenol-induced cardiac fibrosis and inflammation in male mice are driven by early activation of the NLRP3 inflammasome via the P2X7-NEK7 pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: